恆投證券(01476.HK)聘任楊淑飛為副總裁
格隆匯4月22日丨恆投證券(01476.HK)公佈,董事會審議通過了聘任楊淑飛女士為公司副總裁,其任期自2020年4月22日起至公司第四屆董事會屆滿之日止。
楊淑飛女士因公司工作安排調整,於獲委任公司副總裁後已辭任公司財務總監;董事會審議通過了聘任孫航先生為公司財務總監;董事會審議通過了聘任劉佔軍先生為公司合規總監;張偉先生因公司工作安排調整,已辭任公司董事會祕書,張偉先生辭任公司董事會祕書後,仍在公司擔任公司副總裁及聯席公司祕書。
此外,董事會審議通過了聘任張景順先生為公司董事會祕書,其任期自2020年4月22日起至公司第四屆董事會屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.